No black box warning on record for Cystografin

As of the latest FDA labeling reviewed, Cystografin (DIATRIZOATE MEGLUMINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Cystografin medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Severe sensitivity reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents. A history of sensitivity to iodine per se or to other contrast agents is not an absolute contraindication to the use of diatrizoate meglumine, but calls for extreme caution in administration.

No black box warning on record for Cystografin

Other warnings & precautions

WARNINGS Severe sensitivity reactions are more likely to occur in patients with a personal or family history of bronchial asthma, significant allergies, or previous reactions to contrast agents. A history of sensitivity to iodine per se or to other contrast agents is not an absolute contraindication to the use of diatrizoate meglumine, but calls for extreme caution in administration.

Cystografin Black Box Warning

No black box warning on record for Cystografin

Other warnings & precautions

Cystografin Black Box Warning

No black box warning on record for Cystografin

Other warnings & precautions